Related Experiment Video
Updated: Jan 30, 2026

Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents
Published on: March 25, 2016
Role of FoxO Proteins in Cellular Response to Antitumor Agents
Giovanni Luca Beretta1, Cristina Corno2, Nadia Zaffaroni3
1Molecular Pharmacology Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy. giovanni.beretta@istitutotumori.mi.it.
Abstract:
FoxO proteins (FoxOs) are transcription factors with a common DNA binding domain that confers selectivity for DNA interaction. In human cells, four proteins (FoxO1, FoxO3, FoxO4 and FoxO6), with redundant activity, exhibit mainly a positive effect on genes involved in cell cycle, apoptosis regulation and drug resistance. Thus, FoxOs can affect cell response to antitumor agent treatment. Their transcriptional activity depends on post-translational modifications, including phosphorylation, acetylation, and mono/poly-ubiquitination. Additionally, alterations in microRNA network impact on FoxO transcripts and in turn on FoxO levels. Reduced expression of FoxO1 has been associated with resistance to conventional agents (e.g., cisplatin) and with reduced efficacy of drug combinations in ovarian carcinoma cells. FoxO3 has been shown as a mediator of cisplatin toxicity in colorectal cancer. A requirement for FoxO3-induced apoptosis has been reported in cells exposed to targeted agents (e.g., gefitinib). Recently, the possibility to interfere with FoxO1 localization has been proposed as a valuable approach to improve cell sensitivity to cisplatin, because nuclear retention of FoxO1 may favor the induction of pro-apoptotic genes. This review focuses on the role of FoxOs in drug treatment response in tumor cells and discusses the impact of the expression of these transcription factors on drug resistance/sensitivity.
Insights
Forkhead box proteins (FoxOs) influence cancer cell responses to antitumor drugs. Modulating FoxO levels and localization can enhance sensitivity to treatments like cisplatin and gefitinib, impacting drug resistance.
Area of Science:
- Molecular Biology
- Cancer Research
- Pharmacology
Background:
- Forkhead box proteins (FoxOs) are transcription factors regulating cell cycle, apoptosis, and drug resistance.
- FoxOs' activity is modulated by post-translational modifications and microRNA networks.
- Altered FoxO expression is linked to tumor cell resistance to various anticancer agents.
Purpose of the Study:
- To review the role of FoxO transcription factors in tumor cell response to drug treatment.
- To discuss the impact of FoxO expression on drug sensitivity and resistance.
- To explore therapeutic strategies targeting FoxO localization for improved cancer treatment.
Main Methods:
- Literature review of studies investigating FoxO proteins in cancer drug response.
- Analysis of the impact of post-translational modifications and microRNAs on FoxO activity.
- Examination of specific FoxO family members (FoxO1, FoxO3) in relation to drug sensitivity.
Main Results:
- Reduced FoxO1 expression correlates with resistance to cisplatin and reduced efficacy of drug combinations in ovarian cancer.
- FoxO3 mediates cisplatin toxicity in colorectal cancer and is required for gefitinib-induced apoptosis.
- Nuclear retention of FoxO1 enhances sensitivity to cisplatin by promoting pro-apoptotic gene expression.
Conclusions:
- FoxO proteins play a critical role in modulating tumor cell sensitivity and resistance to anticancer drugs.
- Targeting FoxO1 localization presents a promising strategy to overcome drug resistance.
- Understanding FoxO function is crucial for developing novel therapeutic approaches in oncology.
Related Concept Videos
Inflammatory Response I: Vascular and Cellular
Role of Proteins in the Human Body
The Unfolded Protein Response
Regulation of the Unfolded Protein Response
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Subviral Agents

